GH Competitors & Alternatives
Compare Guardant Health Inc with similar stocks in the same industry
Diagnostics & Research
GH
Main Stock$170.69
Tradestie Score
50
Market Cap
$7.81B
Revenue Growth
0.4%
Analyst Upside
+13.8%
Top Competitors
36 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MTD
Mettler-Toledo International
|
$1395.25
|
$26.57B | 32.2 | 41 | Compare |
|
DXCM
DexCom, Inc.
|
$92.34
|
$25.91B | 35.5 | 31 | Compare |
|
LH
Labcorp Holdings Inc.
|
$336.34
|
$23.19B | 27.6 | 49 | Compare |
|
NTRA
Natera, Inc. Common Stock
|
$332.03
|
$22.18B | - | 38 | Compare |
|
DGX
Quest Diagnostics Inc.
|
$244.39
|
$20.36B | 25.6 | 49 | Compare |
|
WAT
Waters Corp
|
$410.70
|
$19.04B | 105.4 | 51 | Compare |
|
ILMN
Illumina Inc
|
$219.40
|
$15.72B | 39.9 | 44 | Compare |
|
MEDP
Medpace Holdings, Inc. Common Stock
|
$620.75
|
$15.28B | 36.0 | 48 | Compare |
|
ICLR
Icon Plc
|
$172.23
|
$14.96B | 264.0 | 44 | Compare |
|
EXAS
Exact Sciences Corp
|
$104.91
|
$10.68B | - | 52 | Compare |
More GH Analysis
Data updated: Aug 23, 2026 | Industry: Diagnostics & Research (SIC 8071)
36 stocks in this industry